TROP MED INFECT DIS 润色咨询

Tropical Medicine and Infectious Disease

出版年份：暂无数据 年文章数：867 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2127224, encodeId=d893212e224e1, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：不到5天收到被拒消息！！速度挺快，很痛快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68583129844, createdName=1562ae551em, createdTime=Thu Apr 20 11:12:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1127274, encodeId=1e72112e27418, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:59 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1127273, encodeId=bb2d112e273ee, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:59 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-04-20 1562ae551em 来自北京

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：不到5天收到被拒消息！！速度挺快，很痛快

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2127224, encodeId=d893212e224e1, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：不到5天收到被拒消息！！速度挺快，很痛快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68583129844, createdName=1562ae551em, createdTime=Thu Apr 20 11:12:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1127274, encodeId=1e72112e27418, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:59 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1127273, encodeId=bb2d112e273ee, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:59 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-29 rayms

    什么是correspondingauthor/通讯作者？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2127224, encodeId=d893212e224e1, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：不到5天收到被拒消息！！速度挺快，很痛快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68583129844, createdName=1562ae551em, createdTime=Thu Apr 20 11:12:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1127274, encodeId=1e72112e27418, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:59 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1127273, encodeId=bb2d112e273ee, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:59 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 rayms

    推荐同行评议时需要注意哪些情况？

    1

    展开1条回复
共5条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分